Literature DB >> 34154617

Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts.

Jeonghyeon Moon1, Seon-Yeong Lee2, Jeong Won Choi2, A Ram Lee2,3, Jin Hee Yoo2, Su-Jin Moon4, Sung-Hwan Park5, Mi-La Cho6,7,8,9.   

Abstract

Entities:  

Year:  2021        PMID: 34154617      PMCID: PMC8218406          DOI: 10.1186/s12967-021-02916-0

Source DB:  PubMed          Journal:  J Transl Med        ISSN: 1479-5876            Impact factor:   5.531


× No keyword cloud information.

Correction to: J Transl Med (2021) 19:192 https://doi.org/10.1186/s12967-021-02860-z

In the original publication [1] there was an incorrect funding section. The incorrect and correct funding information is published in this correction article. The original article has been updated. Incorrect funding This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (Grant Number HI20C1496), the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. NRF-2018R1A2B6007291) and (No. NRF-2018R1C1B6005889). Correct funding This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (Grant Number HI20C1496, HI15C3062), the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. NRF-2018R1A2B6007291) and (No. NRF-2018R1C1B6005889).
  1 in total

1.  Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts.

Authors:  Jeonghyeon Moon; Seon-Yeong Lee; Jeong Won Choi; A Ram Lee; Jin Hee Yoo; Su-Jin Moon; Sung-Hwan Park; Mi-La Cho
Journal:  J Transl Med       Date:  2021-05-04       Impact factor: 5.531

  1 in total
  1 in total

Review 1.  Molecular Basis of Accelerated Aging with Immune Dysfunction-Mediated Inflammation (Inflamm-Aging) in Patients with Systemic Sclerosis.

Authors:  Chieh-Yu Shen; Cheng-Hsun Lu; Cheng-Han Wu; Ko-Jen Li; Yu-Min Kuo; Song-Chou Hsieh; Chia-Li Yu
Journal:  Cells       Date:  2021-12-02       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.